ClinVar Miner

Submissions for variant NM_003477.3(PDHX):c.976G>C (p.Val326Leu)

gnomAD frequency: 0.00574  dbSNP: rs35560997
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000127418 SCV000170981 benign not specified 2014-01-13 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics RCV000224806 SCV000281156 likely benign not provided 2015-08-19 criteria provided, single submitter clinical testing Converted during submission to Likely benign.
Eurofins Ntd Llc (ga) RCV000127418 SCV000341052 benign not specified 2016-05-14 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001000245 SCV000371629 benign Pyruvate dehydrogenase E3-binding protein deficiency 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Labcorp Genetics (formerly Invitae), Labcorp RCV000224806 SCV001111728 benign not provided 2024-01-22 criteria provided, single submitter clinical testing
Mendelics RCV000988526 SCV001138274 likely benign Pyruvate dehydrogenase E1-alpha deficiency 2019-05-28 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000224806 SCV001148229 likely benign not provided 2024-07-01 criteria provided, single submitter clinical testing PDHX: BS2
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV001000245 SCV001156796 benign Pyruvate dehydrogenase E3-binding protein deficiency 2023-09-18 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV003925258 SCV004738415 likely benign PDHX-related disorder 2019-03-19 criteria provided, single submitter clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.